University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...

Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...

Genes contain instructions for making proteins, and a central dogma of biology is that this information flows from DNA to RNA ...

Researchers have identified potential drug targets in glioblastoma cancer stem cells, providing a new approach to treat this ...

For the past decade, scientists have relied almost exclusively on CRISPR-Cas systems for genome editing. Now, a smaller but ...

Richard F. Ludueña, Professor Emeritus at the University of Texas Health San Antonio, discusses his innovative approach to ...

Introduction to HEK 293 Cells HEK 293 cells, also known as Human Embryonic Kidney 293 cells, have become a crucial tool in ...

Nobel Prize winner and UC Berkeley professor Jennifer Doudna presented developments on her gene research at a UC Santa Barbara Arts & Lectures event on Oct. 22.

CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta ...

William Blair analyst Sami Corwin has maintained their bullish stance on CRSP stock, giving a Buy rating yesterday. Sami Corwin’s rating ...